CR MEDICAL (01515) expects a mid-term profit attributable to shareholders of approximately 252 million to 278 million yuan, representing a year-on-year decrease of about 18.1% to 25.9%.
China Resources Medical (01515) announced that the company is preparing its consolidated performance for the six months ending June 30, 2026 (reporting period).
CR MEDICAL (01515) announced that the company is preparing its consolidated results for the six months ending June 30, 2026 (the reporting period). Based on the information currently available and a preliminary assessment of the group's unaudited consolidated management accounts for the reporting period, the company expects the profit attributable to the owners of the company for this period to be approximately RMB 252 million to RMB 278 million, representing a decrease of about 25.9% to 18.1% compared to the profit attributable to the owners of the company for the same period in 2025. However, excluding the one-time management fees and supply chain compensation of approximately RMB 210 million (the Yanhuan case compensation) received by the group in 2025 under the Yanhuan IOT Agreement and the corresponding corporate income tax, the profit attributable to the owners of the company is expected to increase by approximately 36.2% to 50.6% compared to the same period in 2025.
For further details regarding the Yanhuan IOT Agreement and the Yanhuan case compensation, please refer to the announcement of the Yanhuan IOT Agreement. After excluding the impact of the Yanhuan case compensation and the corresponding corporate income tax for the same period in 2025, the expected profit growth is primarily due to an increase in profit contributions from the groups member hospitals, resulting from the groups commitment to enhancing quality and efficiency, optimizing the cost structure, and continuously improving operational management effectiveness. During the reporting period, the group's outpatient and emergency volumes, inpatient admissions, and the proportion of tertiary and quaternary surgeries increased, and the management of medical insurance was further refined. In the second half of 2026, the group will continue to actively improve the income structure, strengthen the daily operational management of member hospitals, and enhance service quality and operational efficiency. The group will continue to explore intelligent health services while actively responding to changes in the external environment and solidifying the foundation of comprehensive medical care.
Related Articles

CHINA RES LAND (01109) reported a cumulative contract sales amount of approximately 130.6 billion yuan for the first seven months, an increase of 5.7% year-on-year.

SOLIS HOLDINGS (02227) intends to sell bonds for 253,000 Singapore dollars.

CHUANGLIAN HOLD(02371): Gao Rui appointed as Executive Director
CHINA RES LAND (01109) reported a cumulative contract sales amount of approximately 130.6 billion yuan for the first seven months, an increase of 5.7% year-on-year.

SOLIS HOLDINGS (02227) intends to sell bonds for 253,000 Singapore dollars.

CHUANGLIAN HOLD(02371): Gao Rui appointed as Executive Director

RECOMMEND





